Browsing Category

44023 posts
SK hynix to Unveil 'Full Stack AI Memory Provider' Vision at CES 2025

SK hynix to Unveil 'Full Stack AI Memory Provider' Vision at CES 2025

– SK hynix to showcase technological capabilities, participating in the world’s largest…

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ — Innovent Biologics,…
TORRAS to Showcase Pioneering Personal Air-Conditioning Cooling Tech and More at CES 2025

TORRAS to Showcase Pioneering Personal Air-Conditioning Cooling Tech and More at CES 2025

HONG KONG, Jan. 3, 2025 /PRNewswire/ — TORRAS, a pioneering consumer electronics…
Govee Partners with IDC to Discuss the Impact of Smart Lighting and the Future of Smart Living In a New Whitepaper

Govee Partners with IDC to Discuss the Impact of Smart Lighting and the Future of Smart Living In a New Whitepaper

In new research for CES 2025, Govee aims to illuminate the next…

DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion

Lending revenue dips against backdrop of record-high indices NEW YORK, Jan. 3,…

CUBE COMPLETES ACQUISITION OF THOMSON REUTERS REGULATORY INTELLIGENCE AND ODEN BUSINESSES

Acquisition delivers an expanded customer base with a deep global subject matter…
CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia,…

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ — Hanx Biopharmaceuticals, CO. Ltd, an…